Insider · CIK 0001808592
Lisa von Moltke
Files at MCRB (Seres Therapeutics, Inc.), ZBIO (Zenas BioPharma, Inc.). First filing Oct 29, 2024, latest Nov 19, 2024.
Lisa von Moltke files SEC Form 4 as officer at MCRB (Seres Therapeutics, Inc.), and also at ZBIO (Zenas BioPharma, Inc.). Since Oct 29, 2024, Lisa von Moltke has reported 0 open-market buys worth $0 and 2 open-market sells worth $3,520, the latest filed on Nov 19, 2024.
A track record needs three past buys with six months of prices behind them; Lisa von Moltke has 0, so none is measured yet.
The newest scored trade: sold $528 of MCRB on Nov 18, 2024, filed Nov 19, 2024, scored 0 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MCRB: Seres Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Seres Therapeutics, Inc. | $528 977 shares | -3% | - | |
| 0Weak | Seres Therapeutics, Inc. | $2,991 4,334 shares | -12% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2025 | ZBIO Zenas BioPharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Apr 17, 2025 |
| Nov 15, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,969 | - | - | 33,392 | Nov 19, 2024 |
| Nov 18, 2024 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -977 | $0.54 | $528 | 32,415 | Nov 19, 2024 |
| Nov 15, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,969 | $0.00 | $0 | 26,719 | Nov 19, 2024 |
| Oct 27, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +13,744 | $0.00 | $0 | 34,757 | Oct 29, 2024 |
| Oct 28, 2024 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,334 | $0.69 | $2,991 | 30,423 | Oct 29, 2024 |
| Oct 27, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -13,744 | $0.00 | $0 | 0 | Oct 29, 2024 |
Questions about Lisa von Moltke
Answered from the filings on this page, as of the latest one.
Is Lisa von Moltke buying or selling?
Not in the last 12 months. Lisa von Moltke's latest open-market trade on SEC Form 4 was sold $528 of MCRB on Nov 18, 2024.
How did Lisa von Moltke's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa von Moltke has 0.
Where does Lisa von Moltke file Form 4?
Lisa von Moltke has filed Form 4 at MCRB (Seres Therapeutics, Inc.) as See Remarks; ZBIO (Zenas BioPharma, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.